Trial Profile
Phase 3 Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Atamestane (Primary) ; Toremifene (Primary) ; Letrozole
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Acronyms CAT
- 22 Aug 2007 Status change from in progress to discontinued.
- 03 Sep 2005 New trial record.